[HTML][HTML] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: a real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng, H Chen… - Journal of thoracic …, 2019 - ncbi.nlm.nih.gov
Background Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
[引用][C] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng, H Chen… - Journal of Thoracic …, 2019 - cir.nii.ac.jp
Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell
lung cancer: A real-world study of a large Chinese cohort | CiNii Research CiNii 国立情報学 …
lung cancer: A real-world study of a large Chinese cohort | CiNii Research CiNii 国立情報学 …
Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng… - Journal of thoracic …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
[PDF][PDF] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng, H Chen, H Hu, Y Li - 2019 - cdn.amegroups.cn
Background: Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
[HTML][HTML] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng, H Chen… - Journal of Thoracic …, 2019 - jtd.amegroups.org
Background: Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort.
Y Jin, X Shen, Y Pan, Q Zheng, H Chen… - Journal of Thoracic …, 2019 - europepmc.org
Background Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
Y Jin, X Shen, Y Pan, Q Zheng, H Chen… - Journal of Thoracic …, 2019 - jtd.amegroups.org
Background: Programmed death ligand-1 (PD-L1) is a predictive marker of anti-programmed
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …
death protein 1 (PD-1)/PD-L1 therapies for non-small cell lung cancer (NSCLC). However …